J&J reports positive survival and outcomes with Impella in HRPCI
JNJ•Johnson & Johnson reported positive survival and outcomes with Impella in HRPCI. Registry data showed lower mortality with Impella than CHIP-BCIS3.
JNJ•JNJ•JNJ•Johnson & Johnson reported positive survival and outcomes with Impella in HRPCI. Registry data showed lower mortality with Impella than CHIP-BCIS3.
Johnson & Johnson said registry data showed lower mortality with Impella in HRPCI than CHIP-BCIS3.
